Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/16643
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | ALONSO ABAD, Ariel | - |
dc.contributor.author | MOLENBERGHS, Geert | - |
dc.contributor.author | Van Breukelen, Gerard | - |
dc.date.accessioned | 2014-04-23T08:22:13Z | - |
dc.date.available | 2014-04-23T08:22:13Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | van Montfort, Kees; Oud, Johan; Ghidey, Wendimagegn (Ed.). Developments in Statistical Evaluation of Clinical Trials, p. 227-246 | - |
dc.identifier.isbn | 9783642553448 | - |
dc.identifier.uri | http://hdl.handle.net/1942/16643 | - |
dc.description.abstract | The increasing cost of drug development has raised the demand on the use of biomarkers as surrogate endpoints for the evaluation of new drugs in clinical trials. However, failed past attempts to use surrogate endpoints made it clear that, before deciding on the use of a candidate surrogate endpoint, it is of the utmost importance to investigate its validity. Such validation process has proven challenging for conceptual and practical reasons. In the present chapter, some of the statistical methods introduced for the evaluation of surrogate markers will be discussed. Emphasis will be made on the so-called meta-analytic approach and its information-theoretic version, where information from several units is combined to carry out the validation exercise. The methods will be illustrated using a case study in ophthalmology. | - |
dc.language.iso | en | - |
dc.publisher | Springer-Verlag | - |
dc.rights | © Springer-Verlag Berlin Heidelberg 2014 | - |
dc.title | Statistical Validation of Surrogate Markers in Clinical Trials | - |
dc.type | Book Section | - |
local.bibliographicCitation.authors | van Montfort, Kees | - |
local.bibliographicCitation.authors | Oud, Johan | - |
local.bibliographicCitation.authors | Ghidey, Wendimagegn | - |
dc.identifier.epage | 246 | - |
dc.identifier.spage | 227 | - |
local.format.pages | 20 | - |
local.bibliographicCitation.jcat | B2 | - |
local.publisher.place | Berlin Heidelberg, Germany | - |
local.type.refereed | Refereed | - |
local.type.specified | Book Section | - |
local.identifier.vabb | c:vabb:378548 | - |
dc.identifier.doi | 10.1007/978-3-642-55345-5_13 | - |
local.bibliographicCitation.btitle | Developments in Statistical Evaluation of Clinical Trials | - |
item.fullcitation | ALONSO ABAD, Ariel; MOLENBERGHS, Geert & Van Breukelen, Gerard (2014) Statistical Validation of Surrogate Markers in Clinical Trials. In: van Montfort, Kees; Oud, Johan; Ghidey, Wendimagegn (Ed.). Developments in Statistical Evaluation of Clinical Trials, p. 227-246. | - |
item.validation | vabb 2016 | - |
item.contributor | ALONSO ABAD, Ariel | - |
item.contributor | MOLENBERGHS, Geert | - |
item.contributor | Van Breukelen, Gerard | - |
item.fulltext | With Fulltext | - |
item.accessRights | Restricted Access | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Chapter 13 sept 02 2013.pdf Restricted Access | 463.39 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
1
checked on Sep 3, 2020
Page view(s)
66
checked on Aug 25, 2023
Download(s)
50
checked on Aug 25, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.